Semax
Semax is a synthetic peptide analog of adrenocorticotropic hormone (ACTH) developed in Russia. It has been shown to increase brain-derived neurotrophic factor (BDNF), improve cerebral blood flow, and provide neuroprotective effects. Used in Russia for treating cognitive impairments and stroke recovery.
Synthetic ACTH analog that enhances BDNF production, improves cerebral circulation, and protects neurons
| Parameter | Detail |
|---|---|
| Administration | Nasal spray |
| Typical Dose | 2-3 drops per nostril 2-3x daily |
| Frequency | Daily |
Common Side Effects
Serious Side Effects
- Pregnancy
- Breastfeeding
- Severe anxiety disorders
- Children
Evidence Quality
Clinical Trial Phase
Preclinical / Not submitted
| Peptide | Monthly Cost | FDA Status |
|---|---|---|
| Semax | $45 - $90/mo | Not submitted |
| Selank | $40 - $80/mo | Not submitted |
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy or medication. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary.